Muscular Dystrophy Association Celebrates FDA Approval of ZILBRYSQ® zilucoplan for the Treatment of Generalized Myasthenia Gravis (gMG) in Adult Patients
New FDA Drug Approval for generalized myasthenia gravis Muscular Dystrophy Association celebrates the US Food and Drug Administration (FDA) approval...
Read more